BICYCLIC PYRIMIDINE MATRIX METALLOPROTEINASE INHIBITORS
    2.
    发明申请
    BICYCLIC PYRIMIDINE MATRIX METALLOPROTEINASE INHIBITORS 审中-公开
    双相PYRIMININE MATRIX金属蛋白酶抑制剂

    公开(公告)号:US20060040957A1

    公开(公告)日:2006-02-23

    申请号:US10071032

    申请日:2002-02-08

    IPC分类号: A61K31/519 C07D498/04

    CPC分类号: C07D487/04 C07D513/04

    摘要: Selective MMP-13 inhibitors are bicyclic pyrimidines of the Formula I or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or alkyl; R2, R3, and R4 include hydrogen, halo, alkyl, C≡C(CH2)m aryl, CO2 alkyl, CO2(CH2)m aryl, COHN alkyl, and CONH(CH2)m aryl; and X is O, S, SO, SO2, CH2, C═O, CHOH, NH, or NR5. A compound of Formula I, or a pharmaceutically acceptable salt thereof, is useful for treating cancer or arthritis.

    摘要翻译: 选择性MMP-13抑制剂是式I的二环嘧啶或其药学上可接受的盐,其中R 1是氢或烷基; R 2,R 3和R 4包括氢,卤素,烷基,C≡C(CH 2)2, )芳基,CO 2烷基,CO 2(CH 2 CH 2)m, 芳基,COHN烷基和CONH(CH 2 CH 2)m芳基; X是O,S,SO,SO 2,CH 2,C-O,CHOH,NH或NR 5。 式I化合物或其药学上可接受的盐可用于治疗癌症或关节炎。